0001209191-21-040944.txt : 20210616 0001209191-21-040944.hdr.sgml : 20210616 20210616170015 ACCESSION NUMBER: 0001209191-21-040944 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210615 FILED AS OF DATE: 20210616 DATE AS OF CHANGE: 20210616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Winslow Garrett CENTRAL INDEX KEY: 0001803773 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39655 FILM NUMBER: 211022164 MAIL ADDRESS: STREET 1: 35 PARKWOOD DRIVE STREET 2: C/O SPRING BANK PHARMACEUTICALS, INC. CITY: HOPKINTON STATE: MA ZIP: 01748 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galecto, Inc. CENTRAL INDEX KEY: 0001800315 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371957007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 100 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 45-70-70-52-10 MAIL ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 100 CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Galecto Inc. DATE OF NAME CHANGE: 20200116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-15 0 0001800315 Galecto, Inc. GLTO 0001803773 Winslow Garrett C/O GALECTO, INC. OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200 DENMARK 0 1 0 0 General Counsel Stock Option (right to buy) 5.61 2021-06-15 4 A 0 120000 0.00 A 2031-06-14 Common Stock 120000 120000 D 25% of the shares subject to such option will vest and become exercisable on May 2, 2022 and the remainder of the shares will vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. /s/ Garrett Winslow 2021-06-16